DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Harpoon Therapeutics Q4 EPS $(0.58) Misses $(0.53) Estimate, Sales $2.234M Miss $3.74M Estimate

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 92.88 percent increase over losses of $(8.15) per share

Benzinga · 03/12/2020 20:13

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 92.88 percent increase over losses of $(8.15) per share from the same period last year. The company reported quarterly sales of $2.234 million which missed the analyst consensus estimate of $3.74 million by 40.27 percent. This is a 110.16 percent increase over sales of $1.063 million the same period last year.